David Hiltzik, MD
Otolaryngology · New York, NYNPI 1336262591
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $15,160 of the $24,860 with a category attached, or 61.0%. Cook Incorporated accounts for 80.7% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2020 at $12,449 and has fallen 83.8% since, to $2,014 in 2025. Among otolaryngology clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 47 payments — averaging $528.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Cook Incorporated$20K
- Aerin Medical Inc.$2K
- Cook Medical LLC$1K
- Intersect ENT, Inc.$360
- Stryker$357
- Regeneron Healthcare Solutions, Inc.$250
- plus $583 from 7 others
What the payments were for
- Consulting fees$6,33025%
- Speaking & faculty fees$15,16061%
- Travel & lodging$6913%
- Food & beverage$2,67911%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Cook Incorporated | 7 | $20,063 |
| Aerin Medical Inc. | 4 | $2,132 |
| Cook Medical LLC | 14 | $1,115 |
| Intersect ENT, Inc. | 5 | $360 |
| Stryker | 4 | $357 |
| Regeneron Healthcare Solutions, Inc. | 2 | $250 |
| Optinose US, Inc. | 4 | $195 |
| Inspire Medical Systems, Inc. | 2 | $158 |
| Olympus America Inc. | 1 | $149 |
| Ambu Inc. | 1 | $28 |
| Acclarent, Inc | 1 | $23 |
| Hologic Sales And Service, LLC | 1 | $17 |
| Smith+Nephew | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Cook Medical Sleep$12,150
- Cook Medical Needles$4,875
- Cook Medical Tongue Base$3,321
- VIVAER STYLUS$2,132
- RHINAER STYLUS$532
- Cook Medical Accessories$336
- N/A$314
- DUPIXENT$250
- PK Diego$149
- Inspire Upper Airway Stimulation System$134
- PROPEL$134
- SINUVA$124
- Xhance$117
How this compares
$24,860 in reported general payments places this provider in the 95th percentile of 701 otolaryngology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XhanceFluticasone Propionate | 17 | $13,738 |
| Mometasone Furoate | 235 | $13,692 |
| Ipratropium Bromide | 324 | $11,850 |
| Levocetirizine Dihydrochloride | 897 | $9,122 |
| Famotidine | 750 | $4,890 |
| Azelastine Hcl | 245 | $4,411 |
| Pantoprazole Sodium | 659 | $4,191 |
| Fluticasone Propionate | 451 | $4,173 |
| Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth | 18 | $2,584 |
| Azelastine-FluticasoneAzelastine/Fluticasone | 11 | $1,269 |
| Montelukast Sodium | 200 | $1,078 |
| Fluocinolone Acetonide Oil | 36 | $1,048 |
| Doxycycline Hyclate | 63 | $918 |
| Triamcinolone Acetonide | 16 | $767 |
| Ofloxacin | 18 | $604 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Optinose US, Inc.Xhance | $195 | $13,73817 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 701 otolaryngology providers in New York.
Other otolaryngology in New York
- Roheen RaithathaNew York$830K
- Dennis KrausNew York$159K
- Anthony DelsignoreNew York$89K
- Satish GovindarajNew York$39K
- Lawrence LustigNew York$33K
- Justin GolubNew York$30K
- Brett MilesNew York$30K
- Milan AminNew York$23K
- Ashutosh KackerNew York$20K
- Michael PitmanNew York$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.